WaveMan
WaveMan · Company
LMRI · Lumexa Imaging Holdings, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

LMRI Lumexa Imaging (LMRI) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-medical laboratories · CIK 0002071288
Quote by TradingView
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
64
13F, latest reported quarter

What the filings say about LMRI

Insiders, 180 days
+$476.9K net bought
2 buyers

Lumexa Imaging insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Lumexa Imaging Holdings, Inc. insiders bought a net $476.9K of stock across 2 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
BRODNAX BRETT
Director
BUY
2026-05-21 SECtraded 2026-05-19
35,000
$253.8K
+45.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 56.4% of the 62,027 shares held after it.
  • 1 other insider bought within 30 days.
  • 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BRODNAX BRETT bought about $253.8K of LMRI on May 19, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 64 funds added in the latest 13F quarter.
Cooper Henry Lee
Director
BUY
2026-05-18 SECtraded 2026-05-14
30,000
$223.2K
+66.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 30,000 shares held after it.
  • 1 other insider bought within 30 days.
  • 64 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cooper Henry Lee bought about $223.2K of LMRI on May 14, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 64 funds added in the latest 13F quarter.
2 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$476.9K over 180 days
more than 89% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
64 funds bought in last quarter
below 74% of Healthcare Services
Revenue
+5.1% year over year (latest quarter)
below 67% of Healthcare Services
Margin
1.0% net margin (latest quarter)
more than 53% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
9.2% of the float short (float per yahoo 2026-10-26) · 4.1 days to cover · settled 2026-09-30
below 62% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch LMRI

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-37.0%12M
-63%-42%-21%+0%2025-122026-022026-032026-052026-072026-092026-10 2026-05-19 · BRODNAX BRETT bought $253.8K2026-05-14 · Cooper Henry Lee bought $223.2K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns LMRI: institutional holders (13F)

13F holdings, latest reported quarter
BROWN ADVISORY INC
5,777,574 sh
$65.2M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
3,453,723 sh
$39.0M
Think Investments LP
2,559,501 sh
$28.9M
Jupiter Topco LLC
2,151,538 sh
$24.3M
BlackRock, Inc.
1,398,112 sh
$15.8M

Congress trades in LMRI

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

LMRI planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

LMRI mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Virtus KAR Health Sciences Fund
$3.3M position · as of 2026-06-30
3.6%
Brown Advisory Small-Cap Fundamental Value Fund
$22.4M position · as of 2026-06-30
1.8%
Putnam VT Small Cap Value Fund
$1.4M position · as of 2026-06-30
1.1%
Putnam Small Cap Value Fund
$2.5M position · as of 2026-05-31
0.8%
MFS New Discovery Value Portfolio
$349.1K position · as of 2026-06-30
0.8%
F/m Emerald Life Sciences Innovation ETF
$738.9K position · as of 2026-05-31
0.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $476.9K bought by insiders over 180 days, 64 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

LMRI financials

Revenue growth
+5.1%
XBRL, annual
Net margin
1.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
1.36x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$1.9B
market value at close 2026-10-23 on 2026-08-12 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.

LMRI Stock Sonar score 5/7 axes

Find similar shapesCompare

LMRI ranks highest on insider conviction (88th percentile) and growth (33rd), and lowest on financial health (25th), among Healthcare Services peers.

HealthGrowthInsidersInstitutionsRisk
Financial health
25
Inputs
  • Debt to equity1.36x · 25 pct, sector of 61
  • Cash flow to debtneeds four quarters of operating cash flow
Growth
33
Inputs
  • Revenue growth, YoY+5.1% · 33 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
88
Inputs
  • Net Form 4 buying (codes P and S), 180d$477K · 89 pct, sector of 64
  • Insider buyers, 180d2 · 87 pct, sector of 64
Institutional and government
26
Inputs
  • Funds adding, latest quarter64 · 26 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
30
Inputs
  • Short interest, % of float+9.2% · 30 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

LMRI filings, in plain words

Are Lumexa Imaging insiders buying or selling LMRI?

In the 180 days to 2026-10-27, Lumexa Imaging insiders were net buyers, a net $476.9K across purchases and sales reported on Form 4, by 2 buyers.

Read the full summary

In the 180 days to 2026-10-27, Lumexa Imaging insiders were net buyers of LMRI, a net $476.9K across purchases and sales reported on Form 4 by 2 buyers. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies